147 related articles for article (PubMed ID: 37584772)
1. Prognosis of repeat hepatectomy for liver transplantable hepatocellular carcinoma recurrence after hepatectomy: a Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO).
Ohira M; Kobayashi T; Hamaoka M; Abe T; Onoe T; Inoue M; Honmyo N; Oishi K; Ohdan H;
Langenbecks Arch Surg; 2023 Aug; 408(1):314. PubMed ID: 37584772
[TBL] [Abstract][Full Text] [Related]
2. Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation.
Yamashita Y; Yoshida Y; Kurihara T; Itoh S; Harimoto N; Ikegami T; Yoshizumi T; Uchiyama H; Shirabe K; Maehara Y
Liver Transpl; 2015 Jul; 21(7):961-8. PubMed ID: 25772591
[TBL] [Abstract][Full Text] [Related]
3. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation.
Lee HS; Choi GH; Joo DJ; Kim MS; Choi JS; Kim SI
Ann Surg Oncol; 2014 Aug; 21(8):2717-24. PubMed ID: 24916744
[TBL] [Abstract][Full Text] [Related]
4. Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis.
Lim C; Shinkawa H; Hasegawa K; Bhangui P; Salloum C; Gomez Gavara C; Lahat E; Omichi K; Arita J; Sakamoto Y; Compagnon P; Feray C; Kokudo N; Azoulay D
Liver Transpl; 2017 Dec; 23(12):1553-1563. PubMed ID: 28945955
[TBL] [Abstract][Full Text] [Related]
5. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
[No Abstract] [Full Text] [Related]
6. [Clinical efficacy and prognostic risk factors of salvage liver transplantation, rehepatectomy, and local ablation in the treatment of postoperative recurrence of hepatocellular carcinoma].
Lin P; You YK; Liu JY; Yang F; Cai QC; Jiang Y; Shen JJ
Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):155-160. PubMed ID: 37137830
[No Abstract] [Full Text] [Related]
7. Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort study.
Bahardoust M; Dehkharghani MZ; Ebrahimi P; Najafirashed M; Mousavi S; Haghmoradi M; Khaleghian M; Tizmaghz A
BMC Surg; 2023 Oct; 23(1):324. PubMed ID: 37875876
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
9. Non-transplantable Recurrence After Resection for Transplantable Hepatocellular Carcinoma: Implication for Upfront Treatment Choice.
Zhang XF; Xue F; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Lv Y; Pawlik TM
J Gastrointest Surg; 2022 May; 26(5):1021-1029. PubMed ID: 34797558
[TBL] [Abstract][Full Text] [Related]
10. Impact of Geriatric Nutritional Risk Index After Initial Hepatectomy for Hepatocellular Carcinoma: a Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO).
Imaoka Y; Ohira M; Kobayashi T; Honmyo N; Hamaoka M; Onoe T; Abe T; Oishi K; Inoue M; Ohdan H;
J Gastrointest Surg; 2023 Jun; 27(6):1152-1158. PubMed ID: 36869207
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma.
Shimada M; Takenaka K; Taguchi K; Fujiwara Y; Gion T; Kajiyama K; Maeda T; Shirabe K; Yanaga K; Sugimachi K
Ann Surg; 1998 Jan; 227(1):80-5. PubMed ID: 9445114
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy.
Chen W; Hu S; Liu Z; Sun Y; Wu J; Shen S; Peng Z
Hepatol Int; 2023 Apr; 17(2):406-416. PubMed ID: 36645648
[TBL] [Abstract][Full Text] [Related]
13. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
Minagawa M; Makuuchi M; Takayama T; Kokudo N
Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
[TBL] [Abstract][Full Text] [Related]
14. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Repeat Hepatectomy for Hepatocellular Carcinoma Patients.
Nanashima A; Tanoue Y; Hiyoshi M; Imamura N; Yano K; Hamada T; Kitamura E; Kai K; Tahira K; Nagayasu T
Anticancer Res; 2022 Sep; 42(9):4553-4561. PubMed ID: 36039454
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
Hu RH; Ho MC; Wu YM; Yu SC; Lee PH
Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
18. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery.
Chen S; Peng Z; Xiao H; Lin M; Chen Z; Jiang C; Hu W; Xie X; Liu L; Peng B; Kuang M
Int J Hyperthermia; 2018 Nov; 34(7):1029-1037. PubMed ID: 28974113
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplant.
Ng KK; Lo CM; Liu CL; Poon RT; Chan SC; Fan ST
Arch Surg; 2008 Jan; 143(1):68-74; discussion 74. PubMed ID: 18209155
[TBL] [Abstract][Full Text] [Related]
20. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
